Revumenib after transplant shows promise in KMT2A-rearranged and NPM1-mutated AML
2:57
Revumenib after transplant shows promise in KMT2A-rearranged and NPM1-mutated AML
21 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Schindler PORT Lifts Santaros Klinikos
1:32
Schindler PORT Lifts Santaros Klinikos
371 viewsApr 30, 2022
YouTubephill_inc
Vilnius University Hospital Santaros Klinikos (English) 2024
5:17
Vilnius University Hospital Santaros Klinikos (English) 2024
596 viewsJun 17, 2024
YouTubeSantaros klinikos
ARCHIVE conditioning enables direct-to-transplant strategy in high-risk AML
3:16
ARCHIVE conditioning enables direct-to-transplant strategy in high-risk AML
15 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Venetoclax combinations show high remission rates in FLT3- and IDH1-mutated AML
3:57
Venetoclax combinations show high remission rates in FLT3- and IDH1-mutated AML
25 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
ARCHIVE conditioning for upfront alloSCT in active AML and high-risk MDS-IB2
5:59
ARCHIVE conditioning for upfront alloSCT in active AML and high-risk MDS-IB2
21 views5 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Precision medicine in AML: from targeted therapy to transplantation
19:54
Precision medicine in AML: from targeted therapy to transplantation
23 views3 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:21
ADVANCED: a novel conditioning regimen for alloSCT in patients with adverse-risk AML
42 viewsJul 15, 2025
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
4:13
HMAs or chemotherapy with venetoclax and gilteritinib for FLT3-mutated AML
26 views6 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
See more
Static thumbnail place holder